Lawmakers Demand Wray Correct the Record
Republicans Call Out Dems for Latest Trump Conspiracy Theory
An Honorary Squad Member Runs for President
Harris Finally Nabs One Crucial But Expected Endorsement
What Trump Told Netanyahu at Mar-a-Lago
Ronny Jackson Shuts Down Those Questioning Whether Trump Was Hit With a Bullet...
Another Day Another Fresh Lie in the Press About Kamala's Past
Speaker Mike Johnson Puts Kamala Harris' Border Failures on Full Display
Trump Announces Plans to Return to the Site of His Would-Be Assassination
Is Gavin Newsom's Latest PR Stunt a Way to Secure Himself a Seat...
Kamala Harris Sits Down With Drag Pro-Palestine Advocates While Boycotting Netanyahu’s Vis...
Kamala Harris' Roadmap to the White House Left Out a Very Crucial Aspect
Dave McCormick's Ad Tying Bob Casey Jr to Kamala Harris Will Run During...
Why One Name Being Considered for the Trump Assassination Attempt Task Force Is...
Was Kamala Harris Complicit in Covering Up for Joe Biden? This Poll Is...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos